Healthcare >> CEO Interviews >> March 11, 2016

Interview with the President & CEO: Cytori Therapeutics Inc. (NASDAQ:CYTX)

Hedrick, Marc H.
Dr. Marc H. Hedrick was appointed President of Cytori Therapeutics Inc. in May 2004 and CEO in 2014. Dr. Hedrick joined the company as Chief Scientific Officer, Medical Director and Director in October 2002. Previously, Dr. Hedrick co-founded and served as President and Chief Executive Officer of StemSource, Inc., a company specializing in stem cell research and development. Dr. Hedrick, a plastic surgeon by training, is a former Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles — UCLA. From 1998 until 2005, Dr. Hedrick directed the Laboratory of Regenerative Bioengineering and Repair for the Department of Surgery at UCLA. Dr. Hedrick obtained his M.D. from the University of Texas Southwestern Medical School, Dallas, and an MBA from UCLA in 2005. Profile
TWST: Was cell therapy technology always a part of Cytori Therapeutics?

Dr. Hedrick: The cell therapy technology actually came a few years after the original